IL-21R inhibitors belong to a chemical class of compounds designed to specifically target and modulate the activity of the Interleukin-21 Receptor (IL-21R). The IL-21R is a cell surface receptor found on various immune cells, and it plays a pivotal role in regulating immune responses. When the cytokine IL-21 binds to IL-21R, it initiates a complex signaling cascade that influences immune cell development, differentiation, and function. The chemical structure of IL-21R inhibitors is engineered to interact with the IL-21R's binding site, obstructing the binding of IL-21 to the receptor. By doing so, these inhibitors disrupt the transmission of cellular signals that would normally occur upon IL-21 binding. This interference can modulate various immune processes and affect the behavior of immune cells.
IL-21R inhibitors can take several forms, such as small molecules, monoclonal antibodies, or other biologic agents. Their design involves intricate molecular engineering and extensive research to ensure specificity in targeting IL-21R and efficacy in blocking its signaling pathway without inducing significant off-target effects.The development of IL-21R inhibitors is a subject of ongoing research in the field of immunology. As scientists continue to explore the molecular mechanisms underlying immune responses, these inhibitors play a crucial role in elucidating the specific roles of IL-21R in the immune system. The chemical class of IL-21R inhibitors holds promise as valuable tools for advancing our understanding of immune regulation.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | ¥2775.00 ¥5528.00 ¥6047.00 | 16 | |
Otro inhibidor de JAK, que puede impedir la activación de las proteínas STAT que normalmente se desencadenarían por la señalización de IL-21. | ||||||
Baricitinib | 1187594-09-7 | sc-364730 sc-364730A | 5 mg 25 mg | ¥2211.00 ¥7345.00 | ||
Un inhibidor de JAK1 y JAK2, que bloquea potencialmente múltiples puntos de la cascada de señalización de la IL-21. | ||||||
TG101348 | 936091-26-8 | sc-364740 sc-364740A | 5 mg 25 mg | ¥2335.00 ¥5810.00 | 6 | |
Inhibe la JAK2, que participa en la vía de señalización de muchas citocinas, incluida la IL-21. | ||||||
GSK2126458 | 1086062-66-9 | sc-364503 sc-364503A | 2 mg 10 mg | ¥2933.00 ¥11609.00 | ||
Un inhibidor de JAK1, que afectaría a la señalización corriente abajo del receptor de IL-21. | ||||||
Filgotinib | 1206161-97-8 | sc-507393 | 10 mg | ¥1692.00 | ||
Inhibe selectivamente JAK1, lo que podría alterar la señalización mediada por IL-21. | ||||||